-
EP4011897
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4011897
| EP4011897 - SALT AND CRYSTAL FORM OF STEROID DERIVATIVE REGULATOR [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 13.05.2022 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 12.02.2021 | Most recent event Tooltip | 30.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Shanghai Hansoh Biomedical Co., Ltd. Building 2 No.3728 Jinke Road Zhangjiang Hi-Tech Park Shanghai 201203 / CN | For all designated states Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Economic and Technological Development Zone Lianyungang, Jiangsu 222047 / CN | [2022/24] | Inventor(s) | 01 /
LI, Zongbin Building 2, No.3728 Jinke Road, Zhangjiang Hi- Tech Park Shanghai 201203 / CN | 02 /
KUANG, Yuanzhuo Building 2, No.3728 Jinke Road, Zhangjiang Hi- Tech Park Shanghai 201203 / CN | 03 /
GUO, Linsong Building 2, No.3728 Jinke Road, Zhangjiang Hi- Tech Park Shanghai 201203 / CN | [2022/24] | Representative(s) | EP&C P.O. Box 3241 2280 GE Rijswijk / NL | [2022/24] | Application number, filing date | 20851145.1 | 05.08.2020 | [2022/24] | WO2020CN107061 | Priority number, date | CN201910726659 | 07.08.2019 Original published format: CN201910726659 | [2022/24] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021023213 | Date: | 11.02.2021 | Language: | ZH | [2021/06] | Type: | A1 Application with search report | No.: | EP4011897 | Date: | 15.06.2022 | Language: | EN | [2022/24] | Search report(s) | International search report - published on: | CN | 11.02.2021 | (Supplementary) European search report - dispatched on: | EP | 22.01.2024 | Classification | IPC: | C07J43/00, C07J5/00, C07J7/00, C07D231/14, A61K31/57, A61K31/573, A61K31/58, A61P25/00, C07D231/12, C07D249/04, C07D257/04, C07D403/06, C07D403/08, C07D413/04 | [2023/42] | CPC: |
A61P25/00 (EP,KR);
C07J43/003 (EP,CN,KR,US);
C07J53/00 (CN);
A61K31/58 (KR);
A61P25/24 (CN);
C07D231/12 (EP);
C07D231/14 (EP);
C07D249/04 (EP);
C07D257/04 (EP);
C07D403/06 (EP);
C07D403/08 (EP);
C07D413/04 (EP);
C07B2200/13 (CN,KR,US)
(-)
|
| Former IPC [2022/24] | C07J5/00, C07J7/00, C07J43/00, C07D231/14, A61K31/57, A61K31/573, A61K31/58, A61P25/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/24] | Title | German: | SALZ UND KRISTALLFORM EINES STEROIDDERIVATREGULATORS | [2022/24] | English: | SALT AND CRYSTAL FORM OF STEROID DERIVATIVE REGULATOR | [2022/24] | French: | SEL ET FORME CRISTALLINE D'UN RÉGULATEUR DE DÉRIVÉ DE STÉROÏDE | [2022/24] | Entry into regional phase | 02.03.2022 | Translation filed | 02.03.2022 | National basic fee paid | 02.03.2022 | Search fee paid | 02.03.2022 | Designation fee(s) paid | 02.03.2022 | Examination fee paid | Examination procedure | 02.03.2022 | Examination requested [2022/24] | 27.06.2024 | Amendment by applicant (claims and/or description) | 27.06.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 02.03.2022 | Renewal fee patent year 03 | 21.08.2023 | Renewal fee patent year 04 | 29.08.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IP]WO2019154257 (JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD [CN], et al); | [E]EP3750908 (JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD [CN], et al); |